[]    Alberts Mark J., Bernstein Richard A., Naccarelli Gerald V., Garcia David A.. Using dabigatran in patients with stroke: a practical guide for clinicians. Stroke; a journal of cerebral circulation.  2012;43:271–279.
[]    Eckman Mark H., Singer Daniel E., Rosand Jonathan, Greenberg Steven M.. Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circulation. Cardiovascular quality and outcomes.  2011;4:14–21.
[]    Eikelboom John W., Wallentin Lars, Connolly Stuart J., et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation.  2011;123:2363–2372.
[]    Tayal A. H., Tian M., Kelly K. M., et al. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology.  2008;71:1696–1701.
[]    Diener Hans-Christoph, Connolly Stuart J., Ezekowitz Michael D., et al. Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial The Lancet Neurology.  2010;9:1157–1163.
[]    Broukhim Michael, Halperin Jonathan L.. Stroke Prevention in the High-risk Atrial Fibrillation Patient: Medical Management. Current cardiology reports.  2011;13:9–17.